89bio Inc (NASDAQ:ETNB) does about 925.97K shares in volume on a normal day but saw 1191721 shares change hands in Tuesday trading. The company now has a market cap of 853.94M USD. Its current market price is $8.68, marking an increase of 2.48% compared to the previous close of $8.47. The 52 week high reached by this stock is $22.93 whilst the lowest price level in 52 weeks is $6.57.
89bio Inc (ETNB) has a 20-day trading average at $8.43 and the current price is -62.15% off the 52-week high compared with 32.02% distance from its 52-week low. The 50-day simple moving average of the closing price is $9.03 and its 200-day simple moving average is $10.65. If we look at the stock’s price movements over the week, volatility stands at 7.50%, which decreases to 6.38% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 51.90 to suggest the stock is neutral.
The consensus objective for the share price is $31.11, suggesting that the stock has a potential upside of 72.1% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on April 22, 2024 when BofA Securities resumed the stock to “Buy” and issued a price target of $30. RBC Capital Mkts downgraded the stock to “Sector Perform” from Outperform on January 12, 2024 at a price target of $24-$15.
89bio Inc (ETNB) stock is up 4.58% over the week and -0.34% over the past month. Its price is -22.29% year-to-date and -57.24% over the past year.
To reach the target analysts have set, the stock logically needs to grow 72.1 percent from here.
The company has a return on investment of -30.83% and return on equity of -34.51%. The beta has a value of 1.00. Price to book ratio is 1.62.
